CVS’s public relations director Michael DeAngelis told Reuters that letters had been sent to a small number of physicians informing them of the decision. A copy of the letter appeared online and said the pharmacy would stop filling prescriptions for schedule II narcotic controlled substances, which include morphine and oxycodone.
Related Articles on Prescription Pain Medicine:
Use of Opioids for Abdominal Pain More Than Doubled in Past Decade
American Medical Association to Help Physicians Prevent Misuse and Abuse of Prescription Opioids
7 Recent Studies & Research Findings on Painkillers
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
